The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused
substantial global morbidity and deaths, leading governments to turn to non-pharmaceutical …

Respiratory syncytial virus (RSV) is one of the most common respiratory viruses. It not only
affects young children but also the elderly and immunocompromised patients. After the …

At the beginning of April 2022, 10 cases of severe acute hepatitis of unknown origin in
children< 10 years of age were reported across central Scotland. Since then, case numbers …

Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract
infection in children younger than 5 years. In 2019, a meta-analysis estimated that RSV was …

Globally, respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and
pneumonia in young children, and the association between severe RSV disease and later …

Nonpharmaceutical interventions (NPIs) were widely introduced to combat the coronavirus
disease 2019 (COVID-19) pandemic. These interventions also likely led to substantially …

Introduction In the first months of the novel coronavirus (COVID-19) pandemic that begun in
2020, non-pharmaceutical interventions (NPIs) have been adopted worldwide. However, the …

Many studies have used mobile device location data to model SARS-CoV-2 dynamics, yet
relationships between mobility behavior and endemic respiratory pathogens are less …

Objectives Using the National Child Mortality Database (NCMD), this work aims to
investigate and quantify the characteristics of children dying of COVID-19, and to identify any …

Background Respiratory syncytial virus (RSV) is the leading global cause of respiratory
infections and is responsible for about 3 million hospitalizations and more than 100,000 …